Notice of Proposed Sale · 144
Arcutis Biotherapeutics, Inc.
ARQTNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- Arcutis Biotherapeutics, Inc.
- Issuer CIK
- 0001787306
- SEC file number
- 001-39186
- Phone
- 805-418-5006
- Person for whose account securities are to be sold
- Terrie Curran
- Relationships to issuer
- Director
- Street
- 3027 Towns Gate Rd Ste 300
- City
- Westlake Village
- State / country code
- CA
- Postal code
- 91361
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 1,072 | 27,912.35 | 125,691,961 | 08/20/2026 | NASDAQ | Merrill Lynch |
Broker / market maker — proposed row 1, entry 1
- Name
- Merrill Lynch
- Street
- 8890 Lyra Drive 5th Floor
- City
- Columbus
- State / country code
- OH
- Postal code
- 43240
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 05/31/2023 | Stock Option Exercise | Arcutis Biotherapeutics | 1,072 | N | 08/20/2026 | Cash |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 08/20/2026
- Signed
- Terrie Curran